News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,027 Results
Type
Article (5008)
Company Profile (17)
Press Release (220002)
Section
Business (82202)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120106)
Policy (7503)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14766)
ALS (19)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3693)
Artificial intelligence (40)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2863)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (439)
Cardiovascular disease (22)
Career advice (392)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16015)
Collaboration (165)
Compensation (167)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (99)
Cystic fibrosis (16)
Data (504)
Depression (5)
Diabetes (40)
Diagnostics (2039)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40778)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37718)
Executive appointments (305)
FDA (3923)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (179)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (107)
Government (411)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2334)
Liver cancer (17)
Lung cancer (53)
Lymphoma (28)
Management (10)
Manufacturing (46)
MASH (27)
Medical device (3860)
Medtech (3861)
Mergers & acquisitions (7423)
Metabolic disorders (118)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (338)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (908)
Now hiring (2)
Obesity (52)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (26)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24574)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4773)
Phase II (6953)
Phase III (5545)
Pipeline (541)
Policy (8)
Postmarket research (625)
Preclinical (1868)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5110)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (22)
Sickle cell disease (7)
Southern California (688)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (6915)
Vaccines (36)
Venture capitalists (2)
Weight loss (20)
Women's health (1)
Date
Today (15)
Last 7 days (99)
Last 30 days (675)
Last 365 days (10037)
2025 (2839)
2024 (11027)
2023 (13193)
2022 (18658)
2021 (19678)
2020 (18239)
2019 (13207)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12119)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11443)
Australia (1606)
California (1903)
Canada (690)
China (70)
Colorado (80)
Connecticut (91)
Delaware (29)
Europe (24486)
Florida (268)
Georgia (33)
Idaho (23)
Illinois (111)
India (6)
Indiana (62)
Iowa (1)
Japan (67)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (219)
Massachusetts (1528)
Michigan (85)
Minnesota (137)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (555)
New Mexico (5)
New York (466)
North Carolina (322)
North Dakota (2)
Northern California (908)
Ohio (55)
Oklahoma (5)
Oregon (3)
Pennsylvania (338)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (4)
Southern California (688)
Tennessee (38)
Texas (222)
Utah (59)
Virginia (43)
Washington D.C. (9)
Washington State (169)
West Virginia (2)
Wisconsin (21)
225,027 Results for "iridex corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Iridex Announces Strategic Investment in the Company
March 20, 2025
·
5 min read
Press Releases
Iridex to Host Strategic Vision Call on April 16, 2025
April 10, 2025
·
1 min read
Press Releases
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
April 14, 2025
·
3 min read
Press Releases
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
March 28, 2025
·
15 min read
Press Releases
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
March 14, 2025
·
1 min read
Press Releases
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
January 14, 2025
·
3 min read
Business
Iridex Reports First Quarter 2024 Financial Results
Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the first quarter ended March 30, 2024, and provided a business update.
May 14, 2024
·
7 min read
Biotech Bay
Iridex Corporation Receives European Patent on MicroPulse TechnologyThe Advanced Short Pulse Laser System
Iridex Corporation (Nasdaq: IRIX) today announced the grant of the European Patent EP 3009093, entitled “Laser System with Short Pulse Characteristics and its Methods of Use”.
February 6, 2024
·
3 min read
Press Releases
Iridex Reports Third Quarter 2024 Financial Results
November 13, 2024
·
10 min read
Business
Iridex Reports Fourth Quarter and Full Year 2023 Financial ResultsAdvances strategic review to unlock shareholder value
Iridex Corporation reported financial results for the fourth quarter and full year ended December 30, 2023, and provided a business update.
March 26, 2024
·
10 min read
1 of 22,503
Next
